About IXICO
IXICO is a company based in London (United Kingdom) founded in 2004. IXICO has completed 1 acquisition, including Optimal Medicine. IXICO offers products and services including IXICO Platform, Imaging Biomarkers, and Trial Management. IXICO operates in a competitive market with competitors including Perspectum, Qure.ai, Zebra Medical Vision, Deeptek and Subtle Medical, among others.
- Headquarter London, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ixico Plc
-
Annual Revenue
$8.78 M (USD)13.32as on Sep 30, 2025
-
Net Profit
-$2.22 M (USD)17.49as on Sep 30, 2025
-
EBITDA
-$2.85 M (USD)11.96as on Sep 30, 2025
-
Latest Funding Round
$5.2 M (USD), Post-IPO
Nov 06, 2024
-
Investors
Gov.uk
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of IXICO
IXICO is a publicly listed company on the LSE with ticker symbol IXI in UK, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of IXICO
IXICO offers a comprehensive portfolio of products and services, including IXICO Platform, Imaging Biomarkers, and Trial Management.
AI-driven tool for neuroimaging and clinical trial data analysis
Provides radiological reads and MRI analysis for disease tracking
Manages global clinical trials data for neurological research
People of IXICO
Unlock access to complete
Unlock access to complete
Funding Insights of IXICO
Investors in IXICO
IXICO has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gov.uk, Cavendish Corporate Finance and SBRI Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delivers business and technological solutions to identify and address healthcare challenges.
|
Locked | Locked | Locked | |
|
Online government services and information are provided to users.
|
Locked | Locked | Locked | |
|
Mid-market investment banking services are provided to clients.
|
Locked | Locked | Locked |
Investor details for IXICO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IXICO
IXICO has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Optimal Medicine.
Investment portfolio details for IXICO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CDS platform for ADHD assessment and treatment is provided.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for IXICO
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - IXICO
Detailed financials for IXICO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ixico Comparisons
Peer comparison for IXICO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IXICO
IXICO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, Zebra Medical Vision, Deeptek and Subtle Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
Detailed competitors of IXICO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ixico
Complete news archive for IXICO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IXICO
IXICO was founded in 2004 and raised its 1st funding round 8 years after it was founded.
IXICO is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Annual revenue of IXICO is $8.78M as on Sep 30, 2025.
AI-based medical image management and analysis solutions for healthcare organizations. It provides clinical trial services for drug development in the field of neurodegeneration. One of their product ASSESSSA assists in decision support to healthcare professionals. The company has two proprietary technology, TrialWire, and TrialTracker, and these are used to collect Alzheimers patients data across the world. Also, they have wearable sensors that allow the measurement of parameters, such as sleep, and activity.
IXICO's top competitors include Perspectum, Qure.ai and Deeptek.
IXICO offers IXICO Platform, Imaging Biomarkers, and Trial Management.
Yes, IXICO is publicly traded on LSE under the ticker symbol IXI.
IXICO has made 1 acquisition, including Optimal Medicine.
IXICO has 3 investors. Key investors include Gov.uk, Cavendish Corporate Finance, and SBRI Healthcare.
The ticker symbol of IXICO is IXI on LSE.